SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-008318
Filing Date
2024-01-30
Accepted
2024-01-30 16:58:12
Documents
5
Period of Report
2024-01-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm244316d2_6k.htm 6-K 16338
2 EXHIBIT 1.1 tm244316d2_ex1-1.htm EX-1.1 224024
3 EXHIBIT 5.1 tm244316d2_ex5-1.htm EX-5.1 26728
4 GRAPHIC tm244316d2_ex5-1img001.jpg GRAPHIC 795
5 GRAPHIC tm244316d2_ex5-1img002.jpg GRAPHIC 4278
  Complete submission text file 0001104659-24-008318.txt   275424
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39179 | Film No.: 24578973
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)